SCHEMBL10429346

SCHEMBL10429346

O=CN(OCc1ccccc1)c1ccc(-c2nsc3c(=O)[nH]nnc23)cc1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121780 0.77 NPSR1 (0.40) HPGDL3MBTL1
SCHEMBL10429347 0.74 ROCK2 (0.50)
SCHEMBL10429313 0.72 NOTUM (0.38) HPGDL3MBTL1
SCHEMBL10429354 0.71 CTSS (0.44)
SCHEMBL10429371 0.71 KDM4E (0.39) HPGD
SCHEMBL10429350 0.70 KDR (0.36) HPGD
SCHEMBL10429367 0.69 HPGD (0.47) HPGDL3MBTL1
SCHEMBL6936315 0.69 TSHR (0.41) HPGDL3MBTL1
SCHEMBL10429340 0.68 NOTUM (0.39) HPGD
SCHEMBL5381471 0.67 NTRK1 (0.41) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP claimed
US-4920119-A XANTHINE OXIDASE INHIBITORS; CONTROL OR PREVENTION OF GOUT OR ISCHEMIA HOFFMANN-LA ROCHE INC. (US) 1990-04-24 US disclosed
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP disclosed